Randomized Phase II Trial of Atovaquone with Pyrimethamine or Sulfadiazine for Treatment of Toxoplasmic Encephalitis in Patients with Acquired Immunodeficiency Syndrome: ACTG 237/ANRS 039 Study
Open Access
- 1 May 2002
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 34 (9), 1243-1250
- https://doi.org/10.1086/339551
Abstract
In this international, noncomparative, randomized phase II trial, we evaluated the effectiveness and tolerance of atovaquone suspension (1500 mg orally twice daily) plus either pyrimethamine (75 mg per day after a 200-mg loading dose) or sulfadiazine (1500 mg 4 times daily) as treatment for acute disease (for 6 weeks) and as maintenance therapy (for 42 weeks) for toxoplasmic encephalitis (TE) in patients infected with human immunodeficiency virus. Twenty-one (75%) of 28 patients receiving pyrimethamine (95% lower confidence interval [CI], 58%) and 9 (82%) of 11 patients receiving sulfadiazine (95% lower CI, 53%) responded to treatment for acute disease. Of 20 patients in the maintenance phase, only 1 experienced relapse. Eleven (28%) of 40 eligible patients discontinued treatment as a result of adverse events, 9 because of nausea and vomiting or intolerance of the taste of the atovaquone suspension. Although gastrointestinal side effects were frequent, atovaquone-containing regimens are otherwise well tolerated and safe and may be useful for patients intolerant of standard regimens for toxoplasmic encephalitis.Keywords
This publication has 19 references indexed in Scilit:
- Dose-escalation, phase I/II study of azithromycin and pyrimethamine for the treatment of toxoplasmic encephalitis in AIDSAIDS, 2001
- Pyrimethamine-Clindamycin vs. Pyrimethamine-Sulfadiazine as Acute and Long-Term Therapy for Toxoplasmic Encephalitis in Patients with AIDSClinical Infectious Diseases, 1996
- Clarithromycin-minocycline combination as salvage therapy for toxoplasmosis in patients infected with human immunodeficiency virusAntimicrobial Agents and Chemotherapy, 1995
- Pyrimethamine plus azithromycin for treatment of acute toxoplasmic encephalitis in patients with AIDSEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993
- Toxoplasmic Encephalitis in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1993
- Comparison of Atovaquone (566C80) with Trimethoprim-Sulfamethoxazole to Treat Pneumocystis carinii Pneumonia in Patients with AIDSNew England Journal of Medicine, 1993
- Doxycycline and Pyrimethamine for Toxoplasmic EncephalitisScandinavian Journal of Infectious Diseases, 1993
- Toxoplasmic Encephalitis in AIDSClinical Infectious Diseases, 1992
- Treatment of Toxoplasmic Encephalitis in Patients with AIDSAnnals of Internal Medicine, 1992
- Pyrimethamine-clarithromycin combination for therapy of acute Toxoplasma encephalitis in patients with AIDSAntimicrobial Agents and Chemotherapy, 1991